# The Effect of Hyoscine-N-butylbromide (HBB, Buscopan) in Augmented Labour Among Primigravidae

> **NCT04349722** · PHASE4 · COMPLETED · sponsor: **National University of Malaysia** · enrollment: 110 (actual)

## Conditions studied

- Labor Long

## Interventions

- **DRUG:** Hyoscine Butylbromide
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04349722
- **Lead sponsor:** National University of Malaysia
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-12-01
- **Primary completion:** 2020-06-30
- **Final completion:** 2020-06-30
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2022-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04349722

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04349722, "The Effect of Hyoscine-N-butylbromide (HBB, Buscopan) in Augmented Labour Among Primigravidae". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04349722. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*